The correlation between PTPRG-AS1 expression and clinicopathological features of glioma patients.
| Clinicopathological features | Cases | The relative expression of PTPRG-AS1 | P value | |
|---|---|---|---|---|
| Low expression (%) | High expression (%) | |||
| Age | P>0.05 | |||
| <50 | 31 | 16 (51.6) | 15 (48.4) | |
| ≥50 | 19 | 8 (42.1) | 11 (57.9) | |
| Sex | P>0.05 | |||
| Male | 27 | 14 (51.9) | 13 (48.1) | |
| Female | 23 | 13 (56.5) | 10 (43.5) | |
| WHO stage | P<0.05 | |||
| I–II | 16 | 11 (68.8) | 5 (31.3) | |
| III–IV | 34 | 7 (20.6) | 27 (79.4) | |
| Tumor volume (cm) | P>0.05 | |||
| T < 3 | 20 | 11 (55.0) | 9 (45.0) | |
| T ≥ 3 | 30 | 14 (46.7) | 16 (53.3) | |